Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.04)
# 2,879
Out of 4,935 analysts
209
Total ratings
25.47%
Success rate
-0.32%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $0.99 | +812.87% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.68 | +1,078.20% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.02 | +215.61% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.25 | +77.78% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.18 | -8.26% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.67 | +1,086.06% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.52 | +653.97% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.12 | +890.57% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.48 | +504.84% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.23 | +4,452.85% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.11 | +800.90% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.50 | +303.71% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.35 | +259.28% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.37 | +127.00% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.55 | +63,861.99% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.72 | +489.32% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.92 | +552.32% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.23 | +8,030.08% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.69 | +2,519.90% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.38 | +740.34% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.34 | +362,803.23% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $14.21 | +3,418.65% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $14.00 | +1,614.29% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.26 | +6,249.21% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.76 | +13,059.63% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.90 | +135,493.22% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.28 | +446.88% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.41 | +1,144.81% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.50 | +1,500.00% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $7.44 | +141.94% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.15 | +20.48% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $5.42 | +26,468.27% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $34.11 | -29.64% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.45 | +235,762.07% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.16 | +1,637,831.03% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $0.99
Upside: +812.87%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.68
Upside: +1,078.20%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.02
Upside: +215.61%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.25
Upside: +77.78%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.18
Upside: -8.26%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.67
Upside: +1,086.06%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.52
Upside: +653.97%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.12
Upside: +890.57%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.48
Upside: +504.84%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.23
Upside: +4,452.85%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.11
Upside: +800.90%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.50
Upside: +303.71%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $8.35
Upside: +259.28%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.37
Upside: +127.00%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.55
Upside: +63,861.99%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.72
Upside: +489.32%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.92
Upside: +552.32%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.23
Upside: +8,030.08%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.69
Upside: +2,519.90%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.38
Upside: +740.34%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.34
Upside: +362,803.23%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $14.21
Upside: +3,418.65%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $14.00
Upside: +1,614.29%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.26
Upside: +6,249.21%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.76
Upside: +13,059.63%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.90
Upside: +135,493.22%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.28
Upside: +446.88%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.41
Upside: +1,144.81%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.50
Upside: +1,500.00%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $7.44
Upside: +141.94%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.15
Upside: +20.48%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $5.42
Upside: +26,468.27%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $34.11
Upside: -29.64%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.45
Upside: +235,762.07%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.16
Upside: +1,637,831.03%